Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 928251, 11 pages
http://dx.doi.org/10.1155/2015/928251
Research Article

Piloting the Impact of Three Interventions on Guaiac Faecal Occult Blood Test Uptake within the NHS Bowel Cancer Screening Programme

1Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK
2Health Behaviour Research Centre, University College London, Gower Street, London WC1E 6BT, UK

Received 30 March 2015; Accepted 2 June 2015

Academic Editor: Amy McQueen

Copyright © 2015 Becky White et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Scholefield, S. Moss, F. Sufi, C. M. Mangham, and J. D. Hardcastle, “Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial,” Gut, vol. 50, no. 6, pp. 840–844, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Mandel, J. H. Bond, T. R. Church et al., “Reducing mortality from colorectal cancer by screening for fecal occult blood,” The New England Journal of Medicine, vol. 328, no. 19, pp. 1365–1371, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Hardcastle, J. O. Chamberlain, M. H. E. Robinson et al., “Randomised controlled trial of faecal-occult-blood screening for colorectal cancer,” The Lancet, vol. 348, no. 9040, pp. 1472–1477, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Kronborg, C. Fenger, J. Olsen, O. D. Jørgensen, and O. Søndergaard, “Randomised study of screening for colorectal cancer with faecal-occult-blood test,” The Lancet, vol. 348, no. 9040, pp. 1467–1471, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Hewitson, P. Glasziou, E. Watson, B. Towler, and L. Irwig, “Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update,” American Journal of Gastroenterology, vol. 103, no. 6, pp. 1541–1549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Parkin, P. Tappenden, A. H. Olsen, J. Patnick, and P. Sasieni, “Predicting the impact of the screening programme for colorectal cancer in the UK,” Journal of Medical Screening, vol. 15, no. 4, pp. 163–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. von Wagner, G. Baio, R. Raine et al., “Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England,” International Journal of Epidemiology, vol. 40, no. 3, pp. 712–718, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Health & Social Care Information Centre (HSCIC), Cervical Screening Programme, England 2012-13, 2013.
  9. Health & Social Care Information Centre (HSCIC), Breast Screening Programme, England, Statistics for 2012-13, 2014.
  10. M. von Euler-Chelpin, K. Brasso, and E. Lynge, “Determinants of participation in colorectal cancer screening with faecal occult blood testing,” Journal of Public Health, vol. 32, no. 3, pp. 395–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Von Wagner, A. Good, D. Wright et al., “Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England,” British Journal of Cancer, vol. 101, no. 2, pp. S60–S63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. J. C. Steele, I. Kostourou, P. McClements et al., “Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme,” Journal of Medical Screening, vol. 17, no. 2, pp. 68–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. Lo, S. Halloran, J. Snowball, H. Seaman, J. Wardle, and C. von Wagner, “Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme,” Gut, vol. 64, no. 2, pp. 282–291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. C. K. Palmer, M. C. Thomas, C. von Wagner, and R. Raine, “Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study,” British Journal of Cancer, vol. 110, no. 7, pp. 1705–1711, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Hewitson, A. M. Ward, C. Heneghan, S. P. Halloran, and D. Mant, “Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial,” British Journal of Cancer, vol. 105, no. 4, pp. 475–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. I. M. Patanwala, V. Brocklebank, J. Inglis, and P. N. Trewby, “A randomized questionnaire-based study on the impact of providing numerical information on colorectal cancer screening,” JRSM Short Reports, vol. 2, no. 6, pp. 48–48, 2011. View at Publisher · View at Google Scholar
  17. S. G. Smith, R. Raine, A. Obichere, M. S. Wolf, J. Wardle, and C. von Wagner, “The effect of a supplementary (‘gist-based’) information leaflet on colorectal cancer knowledge and screening intention: a randomized controlled trial,” Journal of Behavioral Medicine, vol. 38, no. 2, pp. 261–272, 2015. View at Publisher · View at Google Scholar
  18. S. H. Lo, J. Waller, J. Wardle, and C. von Wagner, “Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain,” Journal of Medical Screening, vol. 20, no. 2, pp. 73–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Chapple, S. Ziebland, P. Hewitson, and A. McPherson, “What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study,” Social Science and Medicine, vol. 66, no. 12, pp. 2425–2435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. I. O'Sullivan and S. Orbell, “Self-sampling in screening to reduce mortality from colorectal cancer: a qualitative exploration of the decision to complete a faecal occult blood test (FOBT),” Journal of Medical Screening, vol. 11, no. 1, pp. 16–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ekberg, M. Callender, H. Hamer, and S. Rogers, “Exploring the decision to participate in the national health service bowel cancer screening programme,” European Journal of Cancer Prevention, vol. 23, no. 5, pp. 391–397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Denters, M. Deutekom, P. M. Bossuyt, P. Fockens, and E. Dekker, “A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial,” European Journal of Cancer Prevention, vol. 22, no. 4, pp. 299–304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Wakefield, B. Loken, and R. C. Hornik, “Use of mass media campaigns to change health behaviour,” The Lancet, vol. 376, no. 9748, pp. 1261–1271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Lo, G. Vart, J. Snowball, S. P. Halloran, J. Wardle, and C. Von Wagner, “The impact of media coverage of the Flexible Sigmoidoscopy Trial on English colorectal screening uptake,” Journal of Medical Screening, vol. 19, no. 2, pp. 83–88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Department of Health, Healthy Foundations Life-Stage Segmentation Model Toolkit, Department of Health, National Health Service, London, UK, 2010.
  26. Department for Communities and Local Government, Indices of Multiple Deprivation, 2010.